NVAX FY 2022 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena

NVAXNovavax, Inc.

$2B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.6B+709.3% YoY

Gross Profit

$696M43.5% margin

Operating Income

-$645M-40.3% margin

Net Income

-$658M-41.1% margin

EPS (Diluted)

$-8.42

Cash Flow

Operating Cash Flow

-$416M

Free Cash Flow

-$509M

Stock-Based Comp.

$130M

Balance Sheet

Total Assets

$2.3B

Total Liabilities

$2.9B

Stockholders' Equity

-$634M

Cash & Equivalents

$1.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.6B	$198M	+709.3%
Gross Profit	$696M	$198M	+252.4%
Operating Income	-$645M	-$1.7B	+61.8%
Net Income	-$658M	-$1.7B	+62.3%